Clinical trial

The Semaglutide Study

Active, not recruiting · Not applicable · 1 countries · Registry ID NCT06420739

Active, not recruitingNot applicableObservational

What this study is about

The primary goal of this study is to evaluate the incidence of "full stomach" in fasting elective surgical patients on Semaglutide medication. The other goals are to study the impact of the time interval since the last dose of the medication on the incidence of full stomach and to develop evidence-based recommendations for the perioperative management of these patients.

A promising-looking record is not the same as confirmed eligibility. The study team must review the full criteria and current recruitment status.

Basic eligibility

Age18 Years to Not listed

SexAll

Healthy volunteersNot accepted

ConditionFasting

Full registry criteria

Inclusion Criteria: 1. Patients scheduled for elective surgery at Toronto Western Hospital 2. Aged ≥ 18 years of age 3. American Society of Anaesthesia physical status classification I to III 4. Patients being treated with Semaglutide for at least 1 month Exclusion Criteria: 1. Current pregnancy evidenced by positive urinary pregnancy test 2. Previous surgery of the upper gastrointestinal tract

Treatments and study arms

Gastric Ultrasound

Diagnostic Test

Bedside Gastric Ultrasound to determine the volume and nature of gastric content in patients before their surgery.

Primary outcomes

Incidence of full stomach.Pre-Surgical fasting duration per guideline

Frequency of full stomach in patients taking semaglutide and fasting before surgery. Analysis of the primary outcome will be based on a chi-square analysis.

Study locations

1 locations were listed when this page was built. The first 40 are shown.

Toronto Western Hospital🇨🇦 Toronto, Ontario, Canada

Open map